Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV000984940 | SCV001521445 | likely pathogenic | Succinyl-CoA acetoacetate transferase deficiency | 2020-06-03 | criteria provided, single submitter | clinical testing | This variant was determined to be likely pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. |
Revvity Omics, |
RCV000984940 | SCV002020209 | likely pathogenic | Succinyl-CoA acetoacetate transferase deficiency | 2021-03-01 | criteria provided, single submitter | clinical testing | |
Ai |
RCV002223963 | SCV002502915 | likely pathogenic | not provided | 2022-03-22 | criteria provided, single submitter | clinical testing | |
Institute of Human Genetics, |
RCV000984940 | SCV002526104 | likely pathogenic | Succinyl-CoA acetoacetate transferase deficiency | 2022-04-08 | criteria provided, single submitter | clinical testing | ACMG categories: PM1,PM2,PP3,PP5 |
Center for Genomic Medicine, |
RCV000984940 | SCV004804789 | likely pathogenic | Succinyl-CoA acetoacetate transferase deficiency | 2024-03-17 | criteria provided, single submitter | research | |
Biochemical Molecular Genetic Laboratory, |
RCV000984940 | SCV001132854 | pathogenic | Succinyl-CoA acetoacetate transferase deficiency | 2019-01-29 | no assertion criteria provided | clinical testing |